GH · Guardant Health, Inc. · Executive Compensation

$157.67 +6.80 (+4.50%) Play latest call Q3 2026 earnings call transcript

Russell 1000 member Rebalance outlook locked

Market Cap

$20.41B

135.29M

Volume · Nov 9 682.38K Avg daily vol (3M) 1.99M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ines Dahne-Steuber	Former Chief Operating Officer (a)	$307,101	$50,000	$2,611,538	$2,550,722	—	$317,355	$5,836,716
Darya Chudova	Chief Technology Officer	$424,462	—	$2,222,397	$1,817,482	$279,281	$11,919	$4,755,541
Michael Bell	Chief Financial Officer	$482,000	—	$1,851,413	$1,453,305	$327,375	$9,900	$4,123,993
Christopher Freeman	Chief Commercial Officer	$490,385	—	$1,621,395	$1,075,387	$327,443	$8,442	$3,523,052
Craig Eagle	Chief Medical Officer	$497,462	—	$1,565,107	$1,075,387	$337,500	$9,900	$3,485,356
AmirAli Talasaz	Co-Chief Executive Officer	$1	—	—	—	—	$26,414	$26,415
Helmy Eltoukhy	Chairman and Co-Chief Executive Officer	$1	—	—	—	—	$11,590	$11,591

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Freeman	Chief Commercial Officer	$468,269	—	$1,456,309	$1,882,865	$152,760	$9,364	$3,969,567
Craig Eagle	Chief Medical Officer	$485,231	—	$1,294,507	$1,673,671	$157,262	$6,642	$3,617,313
Michael Bell	Chief Financial Officer	$466,077	—	$604,238	$742,480	$154,958	$9,959	$1,977,712
Helmy Eltoukhy	Chairman and Co-Chief Executive Officer	$1	—	—	—	—	$11,631	$11,632
AmirAli Talasaz	Co-Chief Executive Officer	$1	—	—	—	—	$11,174	$11,175

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Bell	Chief Financial Officer	$439,616	$500,000	$2,941,720	$2,317,493	$250,155	$10,998	$6,459,981
Craig Eagle	Chief Medical Officer	$317,885	$2,370,000	$1,642,986	$1,935,250	$186,390	$3,531	$6,456,043
Christopher Freeman	Chief Commercial Officer	$249,231	$300,000	$2,156,323	$2,539,902	$183,938	$7,056	$5,436,449
John Saia	Chief Legal Officer & Corporate Secretary	$413,654	$30,000	$495,020	$577,753	$187,454	$10,112	$1,713,993
Helmy Eltoukhy	Chairman and Co-Chief Executive Officer	$1	—	—	—	—	$13,664	$13,665
AmirAli Talasaz	Co-Chief Executive Officer	$1	—	—	—	—	$13,270	$13,271

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
AmirAli Talasaz	Co-Chief Executive Officer	$209,937	—	$113,595,323	—	—	$79,780	$113,885,040
Helmy Eltoukhy	Chairman and Co-Chief Executive Officer	$209,937	—	$113,595,323	—	—	$65,726	$113,870,986
John Saia	Chief Legal Officer & Corporate Secretary	$304,346	$30,000	$1,362,000	$1,234,607	$196,800	$9,359	$3,137,112
Michael Wiley	Head of Corporate Affairs	$395,000	—	$1,112,792	—	$227,520	$17,856	$1,753,168
Derek Bertocci	Chief Financial Officer	$376,390	—	—	—	—	$13,510	$389,900

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard Lanman	Global Chief Medical Officer	$433,000	$100,000	$906,534	$1,619,262	—	$7,146	$3,065,942
Michael Wiley	Head of Corporate Affairs	$392,250	—	$543,958	$971,591	$306,323	$1,945	$2,216,067
Derek Bertocci	Chief Financial Officer	$378,313	—	$543,958	$971,591	$226,512	$9,234	$2,129,608
AmirAli Talasaz	Co-Chief Executive Officer	$500,000	—	—	—	$412,500	$2,406	$914,906
Helmy Eltoukhy	Chairman and Co-Chief Executive Officer	$500,000	—	—	—	$412,500	$2,406	$914,906

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Richard Lanman	Global Chief Medical Officer	$367,666	$86,824	—	$338,000	$64,176	$5,926	$862,592
AmirAli Talasaz	President and Chief Operation Officer	$480,000	—	—	—	$336,000	$2,405	$818,405
Helmy Eltoukhy	Chief Executive Officer	$480,000	—	—	—	$336,000	$2,405	$818,405
Michael Wiley	Head of Corporate Affairs	$384,000	—	—	—	$269,000	$1,461	$654,461

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Helmy Eltoukhy	Chief Executive Officer	$460,000	—	—	$3,459,658	$215,050	$1,405	$4,136,113
AmirAli Talasaz	President and Chief Operation Officer	$460,000	—	—	$3,459,658	$215,050	$1,405	$4,136,113
Michael Wiley	Chief Legal Officer	$384,000	—	—	$470,746	$179,520	$1,461	$1,035,727

Executive changes

Person	Role	Change	Effective	Filed
Robert A. Parks	Chief Accounting Officer	Appointed	2026-11-02	2026-11-03
Kevin R. Sayer	Class II director	Appointed	2026-11-02	2026-11-03
Craig Eagle, M.D.	Chief Medical Officer	Resigned	2026-05-08	2026-04-27
Alex M. Azar II	Class III director	Appointed	2025-09-12	2025-09-15
Roberto Mignone	Class I director	Appointed	2024-10-21	2024-10-24
Manuel Hidalgo Medina, M.D., Ph.D.	Class II director	Appointed	2024-07-17	2024-07-18
Samir Kaul	member of the Board	Resigned	2024-02-01	2024-02-01
Ines Dahne-Steuber	Chief Operating Officer	Resigned	2023-11-10	2023-11-03
Ines Dahne-Steuber	Chief Operations Officer	Appointed	2023-05-03	2023-05-08
Musa Tariq	Class I director	Appointed	2023-03-06	2023-02-27
Steve E. Krognes	Class III director	Appointed	2022-06-30	2022-07-07

Leadership

AmirAli Talasaz CEO, Board Member
Helmy Eltoukhy CEO, Chairman, Board Member
Michael Bell CFO
Ines Dahne-Steuber COO
Darya Chudova CTO
Kumud Kalia CIO
John Saia General Counsel
Robert A. Parks Chief Accounting Officer
Alex M. Azar II Board Member
Ian Clark Board Member
Kevin R. Sayer Board Member
Manuel Hidalgo Medina Board Member
Manuel Hidalgo Medina, M.D., Ph.D. Board Member
Meghan Joyce Board Member
Musa Tariq Board Member
Myrtle Potter Board Member
Roberto Mignone Board Member
Steve E. Krognes Board Member
Steve Krognes Board Member
Vijaya Gadde Board Member

Key facts CIK 1576280 CUSIP 40131M109 13F (30d) 297 filings 264 filers Visit website Investor relations